Brief: HLS Therapeutics Files New Drug Submission for Vascepa in Canada
29/04/2019 11:05
April 29 (Reuters) - HLS Therapeutics Inc HLS.TO :
* HLS THERAPEUTICS FILES NEW DRUG SUBMISSION FOR VASCEPA® IN
CANADA
Source text for Eikon: ID:nCNWWScH6a
Further company coverage: HLS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on HLS Therapeutics
See all newsBrief: Hls Therapeutics Increases Normal Course Issuer Bid
Brief: HLS Therapeutics Announces Q2 2026 Financial Results
Canada's HLS Therapeutics Q2 revenue rises on higher cardiovascular drugs demand
Brief: HLS Therapeutics - Secures Nilemdo Reimbursement With Private Payers Covering 80% Of Privately Insured Canadians
Canada Research Roundup: CIBC ,HLS Therapeutics, TD Bank Group